A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain).
Cristina AndrésMaria PiñanaBlanca Borras-BermejoAlejandra González-SánchezDamir García-CehicJuliana EsperalbaAriadna RandoRicardo-Gabriel Zules-OñaCarolina CamposMaria Gema CodinaAlbert Blanco-GrauSergi Colomer-CastellMaria Carmen MartínCarla CastilloKaren García-ComuñasRodrigo Vásquez-MercadoReginaldo Martins-MartinsMagda Campins-MartíTomàs PumarolaJosep QuerAndrés AntónPublished in: Emerging microbes & infections (2021)
ABSTRACTHerein we describe the genetic diversity of circulating SARS-CoV-2 viruses by whole-genome sequencing (WGS) in Barcelona city (Catalonia, Spain) throughout the first four pandemic waves. From weeks 11/2020 to 24/2021, SARS-CoV-2-positive respiratory samples were randomly selected per clinical setting (80% from primary care or 20% from hospital), age group, and week. WGS was performed following the ARTICv3 protocol on MiSeq or NextSeq2000 Illumina platforms. Nearly complete consensus sequences were used for genetic characterisation based on GISAID and PANGOLIN nomenclatures. From 2,475 samples, 2,166 (87%) were fully sequenced (78% from primary care and 22% from hospital settings). Multiple genetic lineages were co-circulating, but four were predominant at different periods. While B.1.5 (50.68%) and B.1.1 (32.88%) were the major lineages during the first pandemic wave, B.1.177 (66.85%) and B.1.1.7 (83.80%) were predominant during the second, third and fourth waves, respectively. Almost all (96.4%) were carrying D614G mutation in the S protein, with additional mutations that define lineages or variants. But some mutations of concern, such as E484 K from B.1.351 and P.1 lineages are currently under monitoring, together with those observed in the receptor binding domain or N-terminal domain, such as L452R and T478 K from B.1.617.2 lineage.The fact that a predominant lineage was observed in each pandemic wave, suggests advantageous properties over other contemporary co-circulating variants. This genetic variability should be monitored, especially when massive vaccination campaign is ongoing because the potential selection and emergence of novel antigenic SARS-CoV-2 strains related to immunological escapement events.